NuVasive is introducing the X360™ system integrated with Pulse™ automation platform for lateral single-position surgery.
Proprietary XLIF®, XALIF™ and XFixation™ procedures are integrated with Pulse, allowing a surgeon to perform multiple procedures from the lateral position throughout the entire surgery. Without patient repositioning, the X360 approach can reduce up to 60 minutes of time in the O.R., reducing anesthesia time and intra-op risk while saving the hospital on average nearly $5,000 per patient.
Navigation technology is designed to support improved line of sight, ease-of-use and surgical efficiency.
Matt Link, President of NuVasive, said, “By incorporating Pulse and, in the future, robotic automation, with X360, we are enhancing the overall O.R. workflow and helping surgeons deliver greater clinical predictability and reproducible outcomes for their patients.”
Source: NuVasive, Inc.
NuVasive is introducing the X360™ system integrated with Pulse™ automation platform for lateral single-position surgery.
Proprietary XLIF®, XALIF™ and XFixation™ procedures are integrated with Pulse, allowing a surgeon to perform multiple procedures from the lateral position throughout the entire surgery. Without patient repositioning, the...
NuVasive is introducing the X360™ system integrated with Pulse™ automation platform for lateral single-position surgery.
Proprietary XLIF®, XALIF™ and XFixation™ procedures are integrated with Pulse, allowing a surgeon to perform multiple procedures from the lateral position throughout the entire surgery. Without patient repositioning, the X360 approach can reduce up to 60 minutes of time in the O.R., reducing anesthesia time and intra-op risk while saving the hospital on average nearly $5,000 per patient.
Navigation technology is designed to support improved line of sight, ease-of-use and surgical efficiency.
Matt Link, President of NuVasive, said, “By incorporating Pulse and, in the future, robotic automation, with X360, we are enhancing the overall O.R. workflow and helping surgeons deliver greater clinical predictability and reproducible outcomes for their patients.”
Source: NuVasive, Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.